April 21st 2025
Keratin hair treatments straighten, smooth, and add shine—though formaldehyde risks raise safety concerns for dermatologists and salon professionals.
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
Revolutionizing Atopic Dermatitis (RAD) Conference 2025
June 6-7, 2025
Register Now!
Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient
July 26, 2025
Register Now!
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis
View More
Dermalorian™ Webinar: Shedding Light on Patient-Reported Outcomes to Assess Disease Severity in Patients With Atopic Dermatitis
View More
Where Do Biologics Fit Into the Management of Moderate-to-Severe Atopic Dermatitis?
View More
Expert Illustrations & Commentaries™: Exploring Novel Therapeutic Targets in Acne Management
View More
Burst CME: Targeted Therapy for Optimal Psoriasis Management
View More
Trial compares responses to BTX-A, BTX-B
March 1st 2002New Orleans - Results of a preliminary, double-blind, parallel group study demonstrate the efficacy of botulinum toxin type A (BTX-A, Botox) 20 units and botulinum toxin type B (BTX-B, Myobloc) 1,000 and 2,000 units for correcting deep glabellar furrows.
Topical tacrolimus improves vitiligo; adding sunlight may help even more
March 1st 2002New Orleans - Results from an exploratory study indicate a potential role for topical tacrolimus in the management of vitiligo, Emil A. Tanghetti, M.D., said at the annual meeting of the American Academy of Dermatology.
Calcium alginate dressing closes cancer defects
March 1st 2002New Orleans - Second intention healing with a calcium alginate dressing can be a useful alternative for closing skin-cancer excision facial defects in select patients who might otherwise be managed with primary closure, local flaps, or skin grafts, Roger H. Weenig, M.D., M.P.H., said at the annual meeting of the American Academy of Dermatology.
The evolution of cosmetic surgery for the common good
February 1st 2002There exists today with both the lay public and some physicians a significantmisunderstanding about who is qualified to perform cosmetic or aestheticsurgical procedures. Perhaps this is the proper time to try and correctsome of the more common misimpressions about this controversy.
Skin substitute may improve post-Mohs appearance
February 1st 2002Chicago - A single application of tissue-engineered, bilayeredskin substitute (Human Skin Substitute, Apligraf) to full-thickness woundscreated from Mohs micrographic or excisional surgery treatment of skin cancersresults in scars slightly more favorable than those healed by secondary-intentionhealing, according to single center study results.